Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-016583
Filing Date
2010-03-30
Accepted
2010-03-30 14:13:43
Documents
11
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v177274_10k.htm 10-K 1971953
2 GRAPHIC chart.jpg GRAPHIC 45620
3 v177274_ex10-13.htm EX-10.13 22008
4 v177274_ex10-14.htm EX-10.14 56480
5 v177274_ex10-15.htm EX-10.15 30032
6 v177274_ex10-16.htm EX-10.16 29694
7 v177274_ex10-17.htm EX-10.17 58210
8 v177274_ex21-1.htm EX-21.1 7678
9 v177274_ex31-1.htm EX-31.1 14791
10 v177274_ex31-2.htm EX-31.2 14047
11 v177274_ex32-1.htm EX-32.1 7808
  Complete submission text file 0001144204-10-016583.txt   2277411
Mailing Address 927 CANADA CT. CITY OF INDUSTRY CA 91748
Business Address 927 CANADA CT. CITY OF INDUSTRY CA 91748 626-581-9098
China Yongxin Pharmaceuticals Inc. (Filer) CIK: 0001087848 (see all company filings)

EIN.: 880420306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26293 | Film No.: 10713266
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries